Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computer-assisted diagnostics: application to prostate cancer.

R J Babaian1, Z Zhang

  • 1Department of Urology, The University of Texas-M.D. Anderson Cancer Center, Houston, Texas 77030-4095, USA. rbabaian@mdanderson.org

Molecular Urology
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a prediction model for low volume/low grade cancer: application in selecting patients for active surveillance.

The Journal of urology·2007
Same author

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.

International journal of radiation oncology, biology, physics·2003
Same author

Complexed prostate-specific antigen improvement in detecting prostate cancer.

Current urology reports·2002
Same author

Radical cystectomy for invasive bladder cancer in the octogenarian.

Oncology reports·2001
Same author

Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.

Oncogene·2001
Same author

Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study.

The Prostate·2001
Same journal

Application of conditionally replicating herpes vector for gene therapy treatment of urologic neoplasms.

Molecular urology·2002
Same journal

Tissue-specific promoters in gene therapy for the treatment of prostate cancer.

Molecular urology·2002
Same journal

Suicide gene therapy for urogenital cancer: current outcome and prospects.

Molecular urology·2002
Same journal

Hammerhead ribozymes as therapeutic agents for bladder cancer.

Molecular urology·2002
Same journal

Application of antisense technology to urologic cancers.

Molecular urology·2002
Same journal

Adenovirus-mediated p53 gene therapy for human cancer.

Molecular urology·2002
See all related articles

Artificial neural networks (ANNs) show promise in prostate cancer diagnosis and treatment prediction, outperforming traditional methods in most studies. Further development of these computer-assisted tools is recommended for improved data analysis.

Area of Science:

  • Oncology
  • Computer Science
  • Biostatistics

Background:

  • Prostate cancer diagnosis, staging, and treatment outcome prediction are critical clinical challenges.
  • Traditional statistical methods have limitations in analyzing complex datasets.
  • Artificial neural networks (ANNs) offer a novel computational approach.

Purpose of the Study:

  • To review and analyze the application of ANNs in prostate cancer.
  • To compare the performance of ANNs against conventional statistical models.
  • To discuss training considerations for ANNs in this domain.

Main Methods:

  • Literature search identifying 10 relevant published journal articles.
  • Analysis of studies comparing ANN performance with logistic regression.

Related Experiment Videos

  • Discussion of specific ANNs training issues and examples.

    • Main Results:

    • ANNs demonstrated superior performance compared to logistic regression in most reviewed studies.
    • One study showed comparable or slightly lesser performance for ANNs.
    • Key training considerations for effective ANN implementation were identified.

    Conclusions:

    • ANNs show significant potential to enhance prostate cancer classification and pattern recognition.
    • Computer-assisted diagnostic methodologies warrant continued development and refinement.
    • ANNs can augment conventional statistical approaches for improved clinical decision-making.